Progressive disease: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{Short description|An overview of progressive disease in the context of oncology}} | |||
== | == Progressive Disease == | ||
[[File:Breast_cancer_cell_(2).jpg|thumb|right|Micrograph of a breast cancer cell, a common site of progressive disease.]] | |||
Progressive disease is a term used in [[oncology]] to describe a condition where [[cancer]] continues to grow or spread in the body despite treatment. It is an important concept in the management and prognosis of cancer patients, as it indicates that the current treatment regimen is not effective in controlling the disease. | |||
== | == Definition == | ||
Progressive | Progressive disease is defined by an increase in the size of existing [[tumors]] or the appearance of new lesions. In clinical trials, it is often assessed using criteria such as the [[Response Evaluation Criteria in Solid Tumors]] (RECIST), which provides standardized guidelines for measuring tumor response to treatment. | ||
== | == Causes == | ||
The | The progression of cancer can be attributed to several factors, including: | ||
* [[Tumor heterogeneity]]: The presence of diverse cell populations within a tumor can lead to the survival of resistant clones. | |||
* [[Genetic mutations]]: Mutations in cancer cells can confer resistance to therapies. | |||
* [[Tumor microenvironment]]: The surrounding environment of a tumor can influence its growth and response to treatment. | |||
== | == Implications for Treatment == | ||
When a patient is diagnosed with progressive disease, it often necessitates a change in treatment strategy. Options may include: | |||
* [[ | * Switching to a different [[chemotherapy]] regimen. | ||
* [[ | * Considering [[targeted therapy]] or [[immunotherapy]]. | ||
* Enrolling the patient in a [[clinical trial]] for experimental treatments. | |||
* [[ | |||
== | == Monitoring and Assessment == | ||
Regular monitoring through [[imaging studies]] such as [[CT scans]], [[MRI]], or [[PET scans]] is crucial for detecting progressive disease. [[Biomarkers]] may also be used to assess disease status and guide treatment decisions. | |||
[[ | == Prognosis == | ||
[[Category: | The prognosis for patients with progressive disease varies depending on the type of cancer, the extent of progression, and the available treatment options. In some cases, aggressive treatment can lead to stabilization or partial response, while in others, the focus may shift to [[palliative care]] to manage symptoms and improve quality of life. | ||
== Related Pages == | |||
* [[Cancer staging]] | |||
* [[Metastasis]] | |||
* [[Oncology]] | |||
* [[Chemotherapy]] | |||
* [[Targeted therapy]] | |||
[[Category:Oncology]] | |||
Latest revision as of 05:51, 16 February 2025
An overview of progressive disease in the context of oncology
Progressive Disease[edit]

Progressive disease is a term used in oncology to describe a condition where cancer continues to grow or spread in the body despite treatment. It is an important concept in the management and prognosis of cancer patients, as it indicates that the current treatment regimen is not effective in controlling the disease.
Definition[edit]
Progressive disease is defined by an increase in the size of existing tumors or the appearance of new lesions. In clinical trials, it is often assessed using criteria such as the Response Evaluation Criteria in Solid Tumors (RECIST), which provides standardized guidelines for measuring tumor response to treatment.
Causes[edit]
The progression of cancer can be attributed to several factors, including:
- Tumor heterogeneity: The presence of diverse cell populations within a tumor can lead to the survival of resistant clones.
- Genetic mutations: Mutations in cancer cells can confer resistance to therapies.
- Tumor microenvironment: The surrounding environment of a tumor can influence its growth and response to treatment.
Implications for Treatment[edit]
When a patient is diagnosed with progressive disease, it often necessitates a change in treatment strategy. Options may include:
- Switching to a different chemotherapy regimen.
- Considering targeted therapy or immunotherapy.
- Enrolling the patient in a clinical trial for experimental treatments.
Monitoring and Assessment[edit]
Regular monitoring through imaging studies such as CT scans, MRI, or PET scans is crucial for detecting progressive disease. Biomarkers may also be used to assess disease status and guide treatment decisions.
Prognosis[edit]
The prognosis for patients with progressive disease varies depending on the type of cancer, the extent of progression, and the available treatment options. In some cases, aggressive treatment can lead to stabilization or partial response, while in others, the focus may shift to palliative care to manage symptoms and improve quality of life.